Human Thromboxane A(2) Receptor Genetic Variants: In Silico, In Vitro and “In Platelet” Analysis

Thromboxane and its receptor have emerged as key players in modulating vascular thrombotic events. Thus, a dysfunctional hTP genetic variant may protect against (hypoactivity) or promote (hyperactivity) vascular events, based upon its activity on platelets. After extensive in silico analysis, six hT...

Descripción completa

Detalles Bibliográficos
Autores principales: Gleim, Scott, Stitham, Jeremiah, Tang, Wai Ho, Li, Hong, Douville, Karen, Chelikani, Prashen, J.Rade, Jeffrey, Martin, Kathleen A., Hwa, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696120/
https://www.ncbi.nlm.nih.gov/pubmed/23840660
http://dx.doi.org/10.1371/journal.pone.0067314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696120/
https://www.ncbi.nlm.nih.gov/pubmed/23840660
http://dx.doi.org/10.1371/journal.pone.0067314

Ejemplares similares